Estimated GFR at month 12 was 65.6 ml/min/1 .73 m with everolimus and 62.2 ml/min/1 .73 m with CNI [ mean difference 3.4 ml/min/1 .73 m compared to CNI control group , 95 % CI -4.9 , 11.8 ml/min/1 .73 m , P = 0.411 ( analysis of covariance adjusting for baseline GFR ) ] .